Skip to main content

Antidepressant Drugs

  • Reference work entry
  • First Online:
Encyclopedia of Molecular Pharmacology

Synonyms

Antidepressants; Mood elevators; Psycho analeptics; Psycho energizers; Thymoleptics

Definition

Antidepressants are small heterocyclic molecules entering the circulation mostly after oral administration and passing the blood–brain barrier to bind at numerous specific sites in the brain. They are used for treatment of depression, panic disorders, generalized anxiety disorder, social phobia, obsessive compulsive disorder, and other psychiatric disorders and nonpsychiatric states.

Mechanism of Action

Most available antidepressants enhance neurotransmission of biogenic amines, mainly norepinephrine and serotonin, to a lesser extent dopamine. Once released from specialized vesicles at the presynaptic nerve terminal, neurotransmitters enter the synaptic cleft and bind to respective receptors at the postsynaptic cell membrane, thus modulating the associated signaling cascades (Fig. 1). Additionally, some of them bind to presynaptically localized receptors that regulate the amount of...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 999.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 1,099.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Agid Y, Buzsáki G, Diamond DM et al (2007) How can drug discovery for psychiatric disorders be improved? Nat Rev Drug Discov 6:189–210

    CAS  PubMed  Google Scholar 

  • Berton O, Nestler EJ (2006) New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 7:137–151

    CAS  PubMed  Google Scholar 

  • Eyre HA, Lavretsky H, Kartika J et al (2016) Modulatory effects of antidepressant classes on the innate and adaptive immune system in depression. Pharmacopsychiatry 49:85–96

    CAS  PubMed  PubMed Central  Google Scholar 

  • Fabbri C, Hosak L, Mössner R et al (2017) Consensus paper of the WFSBP task force on genetics: genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant response. World J Biol Psychiatry 18:5–28

    PubMed  Google Scholar 

  • Fasipe OJ (2019) The emergence of new antidepressants for clinical use: agomelatine paradox versus other novel agents. IBRO Rep 6:95–110

    PubMed  PubMed Central  Google Scholar 

  • Kraus C, Kadriu B, Lanzenberger R et al (2019) Prognosis and improved outcomes in major depression: a review. Transl Psychiatry 9:127

    PubMed  PubMed Central  Google Scholar 

  • Mullins N, Lewis CM (2017) Genetics of depression: progress at last. Curr Psychiatry Rep 19:43

    PubMed  PubMed Central  Google Scholar 

  • Otte C, Gold SM, Penninx BW et al (2016) Major depressive disorder. Nat Rev Dis Primers 2:16065

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ion-George Anghelescu .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Anghelescu, IG., Heuser, I. (2021). Antidepressant Drugs. In: Offermanns, S., Rosenthal, W. (eds) Encyclopedia of Molecular Pharmacology. Springer, Cham. https://doi.org/10.1007/978-3-030-57401-7_8

Download citation

Publish with us

Policies and ethics